127 related articles for article (PubMed ID: 2559127)
1. [NK activity in various liver diseases--especially the relation between NK activity and reserve function of the liver in liver cirrhosis and hepatocellular carcinoma].
Takagi H; Sakurai S; Uehara M; Yamada S; Kobayashi S
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2369-74. PubMed ID: 2559127
[TBL] [Abstract][Full Text] [Related]
2. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H
Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634
[TBL] [Abstract][Full Text] [Related]
3. Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver.
Nakajima T; Mizushima N; Kanai K
Jpn J Clin Oncol; 1987 Dec; 17(4):327-32. PubMed ID: 2826847
[TBL] [Abstract][Full Text] [Related]
4. [Hepatocarcinoma and killer cell activity].
Lucea D; Vargas V; Español T; Castells L; Sauleda S; Esteban R; Guardia J
Med Clin (Barc); 1995 Sep; 105(10):370-3. PubMed ID: 7475439
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic expression of natural killer cell associated membrane antigens in patients with chronic liver disease and hepatocellular carcinoma.
Kakumu S; Hirofuji H; Fuji A; Tahara H; Yoshioka K
J Clin Lab Immunol; 1988 May; 26(1):29-32. PubMed ID: 2846843
[TBL] [Abstract][Full Text] [Related]
6. [Natural killer cell activity of the peripheral blood in patients with hepatocellular carcinoma].
Lin ZY; Weng HZ; Tang ZY; Wang QD
Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):417-20. PubMed ID: 2438105
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
Shiota G; Umeki K; Okano J; Kawasaki H
J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell activity in patients with hepatocellular carcinoma relative to early development and tumor invasion.
Chuang WL; Liu HW; Chang WY
Cancer; 1990 Feb; 65(4):926-30. PubMed ID: 2153437
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study of hepatitis C virus core antigen and HBxAg in liver cirrhosis and hepatocellular carcinoma tissues].
Wang C; Wang W; Lu H
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):85-8. PubMed ID: 10743066
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
[TBL] [Abstract][Full Text] [Related]
12. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.
Jinushi M; Takehara T; Tatsumi T; Hiramatsu N; Sakamori R; Yamaguchi S; Hayashi N
J Hepatol; 2005 Dec; 43(6):1013-20. PubMed ID: 16168521
[TBL] [Abstract][Full Text] [Related]
13. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
Ishiyama K; Ohdan H; Ohira M; Mitsuta H; Arihiro K; Asahara T
Hepatology; 2006 Feb; 43(2):362-72. PubMed ID: 16440347
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
[TBL] [Abstract][Full Text] [Related]
15. Decreased interleukin 1 activity in culture supernatant of lipopolysaccharide stimulated monocytes from patients with liver cirrhosis and hepatocellular carcinoma.
Yokota M; Sakamoto S; Koga S; Ibayashi H
Clin Exp Immunol; 1987 Feb; 67(2):335-42. PubMed ID: 3038436
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma].
Lao XM; Zhang YQ; Guan YX; Guo RP; Lin XJ; Yuan YF; Li JQ; Li GH
Ai Zheng; 2004 Oct; 23(10):1213-7. PubMed ID: 15473939
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
Ohira M; Ohdan H; Mitsuta H; Ishiyama K; Tanaka Y; Igarashi Y; Asahara T
Transplantation; 2006 Dec; 82(12):1712-9. PubMed ID: 17198265
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.
Tsunematsu H; Tatsumi T; Kohga K; Yamamoto M; Aketa H; Miyagi T; Hosui A; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Int J Cancer; 2012 Jan; 130(2):356-64. PubMed ID: 21351090
[TBL] [Abstract][Full Text] [Related]
19. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
Szczepański W
Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
[TBL] [Abstract][Full Text] [Related]
20. Effects of branched-chain amino acid-enriched nutrient mixture on natural killer cell activity in viral cirrhosis.
Takegoshi K; Nanasawa H; Itoh H; Yasuyama T; Ohmoto Y; Sugiyama K
Arzneimittelforschung; 1998 Jun; 48(6):701-6. PubMed ID: 9689432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
